RI-AG03 is an orally active and a BBB-penetrable Tau aggregation peptide inhibitor. RI-AG03 inhibits Tau aggregation and improves associated neurodegeneration and behavioral phenotypes in both in vivo and in vitro models. RI-AG03 can be used in the study of tauopathies such as Alzheimers disease[1][2].
Molecular Weight:
2477.93
Formula:
C104H189N49O22
Target:
Tau Protein
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
